Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics

Hypertension

Volumn 27, Issue 5, 1996, Pages 1173-1179

  Deng, Xiaolin ^a   Welch, William J ^a   Wilcox, Christopher S ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

angiotensin II; L NAME; nitric oxide; renal blood flow; vascular resistance

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; CAPTOPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; ENZYME INHIBITION; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029988736     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.5.1173     Document Type: Article

References (34)

1. Sigmon DH, Carrrtero OA, Beierwaltes WH. Plasma renin activity and the renal response to nitric oxide synthesis inhibition. J Am Soc Nephrol. 1992;3:1288-1294.
2. Sigmon DH, Beierwaltes WH. Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol. 1993;265: R1276-F1283.
3. Alberola AM, Salazar FJ, Nakamura T, Granger JP. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Am J Physiol. 1994;267:R1472-R1478.
4. Baylis C, Harvey J, Engels K. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J Am Sac Nephrol. 1994;5:211-214.
5. Majid DSA, Williams A, Kadowitz PJ, Navar LG. Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension. 1993;22:535-541.
6. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA. 1992;89: 11993-11997.
7. Ito S, Johnson CS, Carretero OA. Modulation of angiotensin II-induccd vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1991;87: 1656-1663.
8. Ohisshi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol. 1992;263:F900-F906.
9. Manning RD Jr, Hu L, Mizelle HL, Granger JP. Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction. Hypertension. 1993;21:949-955.
10. Deng X, Welch WJ, Wilcox CS. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney. Int. 1994; 46:639-646.
11. Tojo A, Madsen KM, Wilcox CS. Expression of immunoreactive nitric oxide synthase isoforms in rat kidney: effects of dietary salt and losartan. Jpn Heart J. 1995;36:389-398.
12. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis. 1994;24:112-119.
13. Noris M, Morigi M, Donadelli R, Aiella S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76:536-543.
14. Alberola A, Pinilla J, Quesada T, Romero JC, Salom NG. Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension. 1992;19:780-784.
15. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int. 1994;46:230-236.
16. Vidal MJ, Romero JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol. 1988;149:401-402.
17. Navarro J, Sanchez A, Saiz J, Ruilope LM, Garcia-Estan J, Romero JC, Moncada S, Laherra V, Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol. 1994;267:R1516-R1521.
18. Greenberg SG, He XR, Schnermann JB, Briggs JP. Studies in isolated j́uxtaglomerular granular cells. Am J Physiol. 1995;268: F948-F952.
19. Welch WJ, Deng X, Snellen H, Wilcox CS. Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. Am J Physiol. 1995;268:F175-F178.
20. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. Spectrophotometer assay for nitrate using NADPH oxidation by aspergillus nitrate reductase. Anal Biochem. 1993;212:359-365.
21. Welch WJ, Wilcox CS, Dunbar KR. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic. Am J Physiol. 1989;257:F554-F560.
22. Welch WJ, Wilcox CS, Aisaka K, Gross SS, Griffith OW, Fontoura T, Maack T, Levi R. Nitric oxide synthesis from L-arginine modulates renal vascular resistance in isolated perfused and intact rat kidneys. J Cardiovasc Pharmacol. 1991;17(suppl 3):S165-S168.
23. Kaiser L. Adjusting for baseline: change or percentage change? Stat Med. 1989;8:1183-1190.
24. NOX V) do not predict vascular NO production. Kidney Int. 1995;48:1272-1279.
25. Marsden PA, Brock TA, Ballermann BJ. Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol. 1990;258:F1295-F1303.
26. Moroi M, Akatsuka N, Fukazawa M, Hara K, Ishikawa M, Aikawa J, Namiki A, Yamaguchi T. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Am J Physiol. 1994:266:H583-H589.
27. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor, Br J Pharmacol. 1994;111:652-654.
28. Nafrialdi BJ, Mimran A. Renin-angiotensin system in the pressor effect of acute N-omega-nitro-L-arginine methyl ester. J Hypertens. 1993;11(suppl 5):324-325.
29. Sigmon DH, Carretero OA, Beierwaltes WH. Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension. 1992;20:643-650.
30. Takenaka T, Mitchell KD, Navar LG. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J Am Soc Nephrol. 1993;4:1046-1053.
31. Baylis C, Engles K, Samsell L, Harton P. Renal effects of acute endothelium-derived relaxing factor blockade are not mediated by angiotensin II. Am J Physiol. 1993;264:F74-F78.
32. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem. 1994;269:11628-11633.
33. Lüscher T. The endothelium in hypertension; bystander, target or mediator? J Hypertens. 1994;12:S105-S116.
34. Lever AF, Robertson JIS. Nicholls MG, eds. The fast and slow presser effects of angiotensin II. In: The Renin-Angiotensin System. London, UK: Gower Medical Publishing: 1993:28.1-9.